BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nayak B, Lal G, Kumar S, Das CJ, Saraya A, Shalimar. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases. Front Cell Infect Microbiol 2021;11:753249. [PMID: 34760721 DOI: 10.3389/fcimb.2021.753249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Adrhyan Araújo DSO, Ana Maisa Passos DS, Jackson Alves DSQ, Paulo Ricardo Freitas DS, Juan Miguel Villalobos S, Deusilene Souza V. ACE2 and TMPRSS2 polymorphisms and the development of COVID-19: a review of the literature. Int J Clin Virol 2022;6:017-023. [DOI: 10.29328/journal.ijcv.1001044] [Reference Citation Analysis]
2 Silva JP, de Lima AB, Alvim LB, Malta FSV, Mendonça CPTB, Fonseca PLC, Moreira FRR, Queiroz DC, Ferreira JGG, Ferreira ACS, Souza RP, Aguiar RS, Zauli DAG. Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program. Viruses 2022;14:847. [DOI: 10.3390/v14050847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Singh DD, Sharma A, Lee H, Yadav DK. SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy. Front Cell Infect Microbiol 2022;12:839170. [DOI: 10.3389/fcimb.2022.839170] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]